Crushing injury of forearm

ST19_CRUSHI_INJURY_FOREA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S57 Cause of death: ICD-10 — S57 2 out of 7 registries used, show all original rules.	52
4. Check minimum number of events None	52
5. Include endpoints None	52
6. Filter based on genotype QC (FinnGen only)	52

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_ELBOW_FOREA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S5
Name in latin: Conquassatio antebrachii

NAME	ST19_CRUSHI_INJURY_FOREA
CONTROL_EXCLUDE	ST19_INJURI_ELBOW_FOREA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S57
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S57
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Crushing injury of forearm based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	52	25	27
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	47.35	48.73	46.07

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
50: Matched controls
500

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S57.0

ICD-10 Finland

Crushing injury of elbow

+∞

30.3

S57.8

ICD-10 Finland

Crushing injury of other parts of forearm

+∞

18.9

S52.5

ICD-10 Finland

Fracture of lower end of radius

38.4

9.9

S52.0

ICD-10 Finland

Fracture of upper end of ulna

+∞

9.7

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

107.4

8.7

S57.9

ICD-10 Finland

Crushing injury of forearm, part unspecified

+∞

7.5

NCU20

NOMESCO Finland

Removal of internal fixation device from elbow or forearm

+∞

7.5

NCJ64

NOMESCO Finland

Other internal fixation of fracture of forearm

+∞

7.5

ZZA00

NOMESCO Finland

Split skin graft

17.1

7.3

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

20.3

7.1

NC2AA

NOMESCO Finland

Forearm X-ray examination

+∞

6.4

QCE35

NOMESCO Finland

Repair of skin defect in upper limb after surgery or injury

+∞

6.4

NCJ62

NOMESCO Finland

Internal fixation of fracture of forearm using plate

+∞

6.4

X59

ICD-10 Finland

Exposure to unspecified factor

5.4

6.1

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

3.84

4.30

2.0

1.6

1110.0

1184.6

nmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

121

3.30

4.27

2.7

2.0

—

(3002256) Pathology report gross observation

4.16

3.89

1.0

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

137

2.80

3.24

3.6

2.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

7.35

2.95

2.8

2.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

5.59

2.83

1.0

1.7

—

(3032080) INR in Blood by Coagulation assay

145

2.59

2.81

5.2

7.1

1.1

1.3

inr

0.33

(3000850) Epithelial cells [#/volume] in Urine

2.51

2.40

2.4

2.0

8.0

4.0

e6/l

0.32

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3.02

2.15

2.9

2.7

—

(3026782) Osmolality of Urine

2.42

2.10

2.6

2.4

597.3

549.9

mosm/kgh2o

0.41

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2.38

2.05

2.5

2.2

—

(3013512) EKG study

112

2.28

2.02

4.1

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

191

2.17

1.96

4.0

3.7

—

(3009343) pH of Capillary blood

3.51

1.96

2.7

3.2

—

7.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.45

1.92

1.9

2.1

0.6

1.0

e6/l

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3.35

1.87

2.9

3.1

5.2

4.9

kpa

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

4.48

1.87

3.4

4.1

24.2

24.4

mmol/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4.48

1.87

1.4

1.5

—

(36304419) Bacteria [Presence] in Urine

117

2.15

1.79

3.0

2.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3.07

1.72

1.6

1.9

0.0

e6/l

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

174

1.99

1.59

10.9

7.0

1.2

mmol/l

0.18

142

(3022313) Gas panel - Capillary blood

3.57

1.56

3.0

3.5

—

(3023368) Bacteria identified in Blood by Culture

2.19

1.52

3.6

5.0

—

(3000330) Specific gravity of Urine by Test strip

2.94

1.48

4.0

3.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.94

1.48

4.0

3.3

27.9

24.7

mmol/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

145

1.90

1.36

3.6

3.4

12.2

35.9

ng/l

0.86

(3003694) ABO and Rh group [Type] in Blood

129

1.89

1.31

1.4

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

274

1.85

1.21

5.7

4.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

235

1.79

1.18

10.7

10.1

3.8

4.1

e9/l

0.41

210

(3026008) Bacteria identified in Urine by Culture

110

1.81

1.08

2.1

3.2

—

(3025159) Blasts/100 leukocytes in Blood

2.22

1.07

2.1

6.8

—

0.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

146

1.74

1.05

2.5

1.9

104.5

91.9

pmol/l

0.72

(3002179) Metamyelocytes/100 leukocytes in Blood

2.09

1.01

1.9

6.6

—

0.7

—

(3018418) pH of Serum or Plasma

105

1.76

0.96

3.9

3.7

7.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2.13

0.90

2.0

2.3

—

(3019225) pH of Specimen

2.05

0.87

4.2

3.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.99

0.85

2.5

1.7

—

(3013115) Eosinophils [#/volume] in Blood

210

1.59

0.84

8.8

6.6

0.2

e9/l

0.13

186

(3015736) pH of Urine

156

1.58

0.78

3.1

3.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.97

0.77

4.6

5.1

498.3

255.4

u/l

—

(40768804) Tissue Pathology biopsy report

139

1.58

0.75

2.5

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.86

0.75

2.7

1.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

410

1.72

0.67

16.6

11.3

88.7

86.6

ml/min/173m2

0.23

328

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.80

0.65

1.2

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.67

0.64

1.0

1.7

—

(40768797) Stomach Pathology biopsy report

1.63

0.63

1.4

1.2

—

(4035726)

1.81

0.60

1.2

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.57

0.58

1.1

1.8

—

(40761536) Microorganisms panel - Urine sediment

1.65

0.56

2.3

3.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.42

0.0

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.52

0.41

25.8

6.1

1.7

1.5

mmol/l

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.41

0.0

1.6

—

(42870588) Differential panel, method unspecified - Blood

127

1.38

0.40

11.0

5.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.48

0.37

3.8

5.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

425

1.44

0.34

21.5

11.5

39.9

41.2

0.35

337

(46235355) HIV 1 and 2 tests - Meaningful Use set

112

1.34

0.33

1.6

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.36

0.31

1.2

1.7

—

(40761511) CBC panel - Blood by Automated count

465

0.76

0.31

18.2

10.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.29

0.29

1.4

1.5

—

(21494755) Public health laboratory ask at order entry panel

1.32

0.28

1.0

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

125

1.28

0.26

5.6

3.9

12.4

21.2

—

(3003396) Base excess in Arterial blood by calculation

1.31

0.23

29.8

7.8

0.6

0.2

mmol/l

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.21

0.0

1.9

—

165.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.1

—

(3024928) Oxygen saturation in Venous blood

0.00

0.21

0.0

3.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

2.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.21

0.0

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

22.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.21

0.0

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.31

0.21

1.7

2.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.21

0.0

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.28

0.21

1.7

1.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

10.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3022145) Colonoscopy Study observation

1.25

0.21

1.0

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.20

0.0

1.1

—

(40768443) Skin Pathology biopsy report

0.00

0.20

0.0

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.20

0.0

1.2

—

(3042936) Bacteria identified in Isolate by Culture

1.17

0.20

2.3

1.7

—

(40758558) Short blood count panel - Blood

1.26

0.19

10.4

7.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.27

0.19

2.1

3.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

111

1.23

0.18

4.8

5.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.18

0.11

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.18

0.10

1.2

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

315

1.13

0.10

2.9

3.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.83

0.09

3.0

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.77

0.09

1.2

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.08

0.08

2.8

2.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

130

1.11

0.05

4.1

3.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

312

1.07

0.02

5.3

3.9

12.5

10.1

mm/h

0.67

291

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

323

1.06

0.01

4.4

3.0

41.0

41.4

u/l

0.02

311

(3044889) 12 lead EKG panel

286

0.95

0.00

4.1

3.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

103

0.96

0.00

1.2

1.4

4.4

2.4

g/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

168

1.02

0.00

3.7

—

(1761868) Lipid panel - Serum or Plasma

192

0.98

0.00

3.4

2.4

—

(3002385) Erythrocyte distribution width [Ratio]

378

1.02

0.00

24.8

13.7

13.5

13.4

0.11

370

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.7

—

2.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

0.00

0.0

11.0

—

12.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

0.00

0.0

7.8

—

0.6

—

(3011648) Oxygen content in Venous blood

0.00

0.0

3.0

—

13.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.0

1.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

2.6

—

68.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.0

2.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.4

—

(3000494) Fungus identified in Specimen by Culture

0.92

0.00

1.2

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.0

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.00

0.0

1.4

—

93.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.0

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

2.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.4

—

6.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.96

0.00

2.9

2.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

0.0

2.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

2.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

6.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

0.0

1.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

6.0

—

4.5

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

7.9

—

58.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

0.00

0.0

3.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_CRUSHI_INJURY_FOREA – Crushing injury of forearm

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Crushing injury of forearm

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Crushing injury of forearm (ST19_CRUSHI_INJURY_FOREA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints